Leukemias principles practice therapy (8 Ergebnisse)

Zustand: Good. This is an ex-library book and may have the usual library/used-book markings inside.This book has hardback covers. In good all round condition. No dust jacket. Please note the Image in this listing is a stock photo and may not match the covers of the actual item,1550grams, ISBN:9781405182355. …

Zustand: New.

Zustand: As New. Unread book in perfect condition.

Zustand: New.

Zustand: New. Brand new! Please provide a physical shipping address.

Zustand: New. Edited by experts from one of the world's largest leukemia centers, this book provides information on the biology of the variety of leukemic disorders, up-to-date diagnostic testing and many new developments in therapy. Editor(s): Faderl, Stefan H.; Kantarjian, Hagop. Num Pages: 456 pages, Illustrations (some col.). BIC Classification: MJCL; MJF. Category: (P) Professional & Vocational. Dimension: 286 x 222 x 25. Weight in Grams: 1504. . 2010. 1st Edition. Hardcover. . . . .…

Zustand: New. Edited by experts from one of the world's largest leukemia centers, this book provides information on the biology of the variety of leukemic disorders, up-to-date diagnostic testing and many new developments in therapy. Editor(s): Faderl, Stefan H.; Kantarjian, Hagop. Num Pages: 456 pages, Illustrations (some col.). BIC Classification: MJCL; MJF. Category: (P) Professional & Vocational. Dimension: 286 x 222 x 25. Weight in Grams: 1504. . 2010. 1st Edition. Hardcover. . . . . Books ship from the US and Ireland.…

Buch. Zustand: Neu. Neuware - Edited by experts from one of the world's largest leukemia centers, this book provides information on the biology of the variety of leukemic disorders, up-to-date diagnostic testing and many new developments in therapy. Chapters covering new treatments present an outlook for the future and explain the rationale for ongoing clinical trials.Topics include:\* Targeted therapy, e.g. tyrosine kinase inhibitors (Flt3, Aurora kinase inhibitors, kit inhibitors, BCR-ABL inhibitors)\* Ras inhibitors\* Epigenetic therapy (hypomethylaters and histone deacetylase inhibitors)\* Lenalidomide analogs\* New chemotherapy drugs, e.g. clofarabine, cloretazine, sapacitabine, forodesine\* Combinations of chemotherapy with kinase inhibitors (e.g. ALL induction protocols in combination with dasatinib or imatinib)\* New monoclonal antibodies (lumiliximab, humaxCD20, anti-CD40)\* Thrombopoietic agentsLeukemias: Principles and Practice of Therapy\* Includes practical information to guide you in challenging situations, such as treatment of elderly patients, pregnancy, relapsed and refractory disease\* Incorporates chapters on supportive care and pharmacologic information about the most frequently used drugs in this area.…